Showing results (141-150 of 191) with videos related to

Sort By:
Pageof 20
Cell Death & Disease|June 18, 2025
PI3K-dependent GAB1/Erk phosphorylation renders head and neck squamous cell carcinoma sensitive to PI3Kα inhibitorsXu Zhang, Jiao Xu, Xuan Wang, et al.
Frontiers in Cellular and Infection Microbiology|December 24, 2025
The composition of lower genital tract microbiota correlates with in vitro fertilization and frozen embryo transfer outcomes in women with polycystic ovarian syndromeYaoyao Tu, Zhiyang Zhou, Ye Lu, et al.
Scientific Reports|July 5, 2024
A retrospective study on the impact of radiotherapy on the survival outcomes of small cell lung cancer patients based on the SEER databaseYao Chen, Ling Yao, Qingquan Chen, et al.
Oncotarget|May 20, 2017
Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancerYixiang Zhang, Yeqing Yuan, Pei Liang, et al.
International Journal of Biological Macromolecules|November 23, 2024
Ixochymostatin, a trypsin inhibitor-like (TIL) protein from Ixodes scapularis, inhibits chymase and impairs vascular permeabilityLarissa Almeida Martins, Markus Berger, Jan Kotál, et al.
Mbio|June 25, 2020
The Response of Acinetobacter baumannii to Hydrogen Sulfide Reveals Two Independent Persulfide-Sensing Systems and a Connection to Biofilm RegulationBrenna J C Walsh, Jiefei Wang, Katherine A Edmonds, et al.
Nephron. Experimental Nephrology|September 24, 2005
Apolipoprotein E regulates primary cultured human mesangial cell proliferationYixiang Zhang, Yuichiro Yasumoto, Toru Ikeda, et al.
Cancer Research|August 27, 2009
Inhibitors of deacetylases suppress oncogenic KIT signaling, acetylate HSP90, and induce apoptosis in gastrointestinal stromal tumorsThomas Mühlenberg, Yixiang Zhang, Andrew J Wagner, et al.
ACS Medicinal Chemistry Letters|June 19, 2024
Lead Identification of Novel Naphthyridine Derivatives as Potent SOS1 InhibitorsDongsheng Li, Qing Xie, Maozhi Yang, et al.
European Journal of Medicinal Chemistry|September 13, 2024
Discovery of orally bioavailable phosphonate prodrugs of potent ENPP1 inhibitors for cancer treatmentShanyun Gao, Yingjie Hou, Yanxiao Xu, et al.
Pageof 20